Moriyama Takaya, Metzger Monika L, Wu Gang, Nishii Rina, Qian Maoxiang, Devidas Meenakshi, Yang Wenjian, Cheng Cheng, Cao Xueyuan, Quinn Emily, Raimondi Susana, Gastier-Foster Julie M, Raetz Elizabeth, Larsen Eric, Martin Paul L, Bowman W Paul, Winick Naomi, Komada Yoshihiro, Wang Shuoguo, Edmonson Michael, Xu Heng, Mardis Elaine, Fulton Robert, Pui Ching-Hon, Mullighan Charles, Evans William E, Zhang Jinghui, Hunger Stephen P, Relling Mary V, Nichols Kim E, Loh Mignon L, Yang Jun J
Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, USA; Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan.
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
Lancet Oncol. 2015 Dec;16(16):1659-66. doi: 10.1016/S1470-2045(15)00369-1. Epub 2015 Oct 28.
Hereditary predisposition is rarely suspected for childhood acute lymphoblastic leukaemia (ALL). Recent reports of germline ETV6 variations associated with substantial familial clustering of haematological malignancies indicated that this gene is a potentially important genetic determinant for ALL susceptibility. Our aims in this study were to comprehensively identify ALL predisposition variants in ETV6 and to determine the extent to which they contributed to the overall risk of childhood ALL.
Whole-exome sequencing of an index family with several cases of ALL was done to identify causal variants for ALL predisposition. Targeted sequencing of ETV6 was done in children from the Children's Oncology Group and St Jude Children's Research Hospital front-line ALL trials. Patients were included in this study on the basis of their enrolment in these clinical trials and the availability of germline DNA. ETV6 variant genotypes were compared with non-ALL controls to define ALL-related germline risk variants. ETV6 variant function was characterised bioinformatically and correlated with clinical and demographic features in children with ALL.
We identified a novel non-sense ETV6 variant (p.Arg359X) with a high penetrance in an index family. Subsequent targeted sequencing of ETV6 in 4405 childhood ALL cases identified 31 exonic variants (four non-sense, 21 missense, one splice site, and five frameshift variants) that were potentially related to ALL risk in 35 cases (1%). 15 (48%) of 31 ALL-related ETV6 variants clustered in the erythroblast transformation specific domain and were predicted to be highly deleterious. Children with ALL-related ETV6 variants were significantly older at leukaemia diagnosis than those without (10·2 years [IQR 5·3-13·8] vs 4·7 years [3·0-8·7]; p=0·017). The hyperdiploid leukaemia karyotype was highly over-represented in ALL cases harbouring germline ETV6 risk variants compared with the wild-type group (nine [64%] of 14 cases vs 538 [27%] of 2007 cases; p=0·0050).
Our findings indicated germline ETV6 variations as the basis of a novel genetic syndrome associated with predisposition to childhood ALL. The development of recommendations for clinical interventions and surveillance for individuals harbouring ALL-related ETV6 variants are needed.
US National Institutes of Health and American Lebanese Syrian Associated Charities.
儿童急性淋巴细胞白血病(ALL)很少怀疑有遗传易感性。最近关于与血液系统恶性肿瘤大量家族聚集相关的胚系ETV6变异的报道表明,该基因是ALL易感性的一个潜在重要遗传决定因素。我们在本研究中的目的是全面鉴定ETV6中ALL的易感变异,并确定它们对儿童ALL总体风险的影响程度。
对一个有几例ALL病例的索引家族进行全外显子组测序,以鉴定ALL易感性的致病变异。对儿童肿瘤学组和圣裘德儿童研究医院一线ALL试验中的儿童进行ETV6的靶向测序。根据这些临床试验的入组情况和胚系DNA的可用性,将患者纳入本研究。将ETV6变异基因型与非ALL对照进行比较,以定义与ALL相关的胚系风险变异。通过生物信息学方法对ETV6变异功能进行表征,并与ALL儿童的临床和人口统计学特征进行关联。
我们在一个索引家族中鉴定出一种新的高外显率的无义ETV6变异(p.Arg359X)。随后对4405例儿童ALL病例进行ETV6靶向测序,发现31个外显子变异(4个无义变异、21个错义变异、1个剪接位点变异和5个移码变异),其中35例(1%)可能与ALL风险相关。31个与ALL相关的ETV6变异中有15个(48%)聚集在成红细胞转化特异性结构域,预计具有高度有害性。携带与ALL相关ETV6变异的儿童在白血病诊断时的年龄显著大于未携带的儿童(10.2岁[四分位间距5.3 - 13.8] vs 4.7岁[3.0 - 8.7];p = 0.017)。与野生型组相比,携带胚系ETV6风险变异的ALL病例中,超二倍体白血病核型的比例过高(14例中的9例[64%] vs 2007例中的538例[27%];p = 0.0050)。
我们的研究结果表明,胚系ETV6变异是一种与儿童ALL易感性相关的新型遗传综合征的基础。需要制定针对携带与ALL相关ETV6变异个体的临床干预和监测建议。
美国国立卫生研究院和美国黎巴嫩叙利亚联合慈善机构。